PEDIATRICS Vol. 87 No. 2 February 1991, pp. 266-267
This Article
Right arrow Full Text (PDF)
Right arrow P3Rs: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when P3Rs are posted
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by MCABEE, G.
Right arrow Articles by MOFENSON, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by MCABEE, G.
Right arrow Articles by MOFENSON, H.

Phenytoin (Dilantin) Prescribing Practices Among Long Island, NY Pediatricians

GARY MCABEE DO1, VIJAYA ATLURU MD2, THOMAS CARACCIO PHARMD3, and HOWARD MOFENSON MD3

1 Nassau County Medical Center, East Meadow, New York
2 Winthrop University Hospital, Mineola, New York
3 Long Island Poison Control Center

To the Editor.—

A recent increase in phenytoin (PHT) toxicity in children prompted us to investigate prescribing practices of pediatricians in Long Island, NY. Questionnaires, consisting of 18 questions regarding the use, kinetics, and side effects of PHT, were sent to 603 pediatricians. There were 97 respondents (16%). Of the respondents, 29% originally prescribed PHT themselves (n = 76 = number who responded to question). The mean number of children treated per month was 2.3 (range 1 to 12).